3rd Circ. Already OK'd Lipitor State Claims, Health Plans Say
By Dani Kass · May 15, 2018, 6:43 PM EDT
The Third Circuit has already cleared a group of health plans that paid for the blockbuster cholesterol medication Lipitor to bring antitrust litigation against Pfizer Inc. and Ranbaxy Inc. based on...
To view the full article, register now.